Related Experiment Videos
Quantification of experimental pulmonary metastases by image analyzer
M Iwahana1, A Tohgo, N G Tanaka
1Exploratory Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo Japan.
In Vivo (Athens, Greece)
|July 1, 1991
Summary
New image analysis quantifies lung metastases more effectively than traditional counting. This method revealed adriamycin
Area of Science:
- Oncology
- Medical Imaging
- Pharmacology
Background:
- Pulmonary metastases quantification is crucial for cancer research.
- Current methods like manual counting have limitations in sensitivity.
- Accurate measurement of metastatic burden is essential for evaluating treatment efficacy.
Purpose of the Study:
- To develop and validate novel image analysis techniques for quantifying experimental pulmonary metastases.
- To compare the sensitivity of image analysis with traditional counting methods for detecting drug effects.
- To evaluate the inhibitory effect of adriamycin on spontaneous lung metastases using the developed image analysis method.
Main Methods:
- Utilized Lewis lung carcinoma (3LL) and B16 melanoma models.
- Developed image analysis techniques to differentiate and quantify metastatic colonies.
- Stained lung parenchyma to enable automated analysis of metastatic foci size and number.
- Administered adriamycin to assess its inhibitory effect on spontaneous metastases.
Main Results:
- Image analysis successfully differentiated metastatic colonies from lung parenchyma.
- Automated determination of metastatic foci size and number was achieved.
- Image analysis detected a significant reduction in metastatic foci area following adriamycin treatment.
- The inhibitory effect of adriamycin was not detected by the conventional counting method.
Conclusions:
- Image analysis provides a more sensitive method for quantifying pulmonary metastases compared to traditional counting.
- This technique is valuable for evaluating the efficacy of anti-cancer agents like adriamycin.
- Automated image analysis offers a robust tool for preclinical cancer metastasis research.